eli lilly weight loss drug retatrutide Medscape | Retatrutide, Lilly's first-in-class triple hormone receptor agonist, delivered meaningful at 80 weeks in all doses in the Eli Lilly's Next-Gen Obesity Drug

What compounding means Compounded tirzepatide is produced by licensed compounding pharmacies rather than the original manufacturer (Eli Lilly)

Sometimes people assume the medication itself is making them tired, when in fact they are just not eating enough

Zhu H, et al

Glossary of common terms GLP-1 RA (Glucagon-Like Peptide-1 Receptor Agonist): A class of medicines that mimic the GLP-1 hormone to improve insulin secretion, reduce appetite, and slow stomach emptying

GLP-1 based therapeutics: simultaneously combating T2DM and obesity

The NICE guidelines (NG28) recognise GLP-1 receptor agonists as valuable treatment options for adults with type 2 diabetes inadequately controlled on other therapies